Literature DB >> 27825516

Adaptation of Escherichia coli traversing from the faecal environment to the urinary tract.

Karen L Nielsen1, Marc Stegger2, Paul A Godfrey3, Michael Feldgarden3, Paal S Andersen4, Niels Frimodt-Møller5.   

Abstract

The majority of extraintestinal pathogenic Escherichia coli (ExPEC) causing urinary tract infections (UTI) are found in the patient's own gut flora, but only limited knowledge is available on the potential adaptation that may occur in the bacteria in order to traverse the perineum and successfully infect the urinary tract. Here, matching pairs of faecal and UTI isolates from 42 patients were compared pairwise using in-depth whole-genome sequencing to investigate whether genetic changes were evident for successful colonization in these two different environments. The identified non-synonymous mutations (0-12 substitutions in each pair) were primarily associated to genes encoding virulence factors and nutrient metabolism; and indications of parallel evolution were observed in genes encoding the major phase-variable protein antigen 43, a toxin/antitoxin locus and haemolysin B. No differences in virulence potential were observed in a mouse UTI model for five matching faecal and UTI isolates with or without mutations in antigen 43 and haemolysin B. Variations in plasmid content were observed in only four of the 42 pairs. Although, we observed mutations in known UTI virulence genes for a few pairs, the majority showed no detectable differences with respect to mutations or mobilome when compared to their faecal counterpart. The results show that UPECs are successful in colonizing both the bladder and gut without adaptation. Copyright Â
© 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Evolution; Faecal flora; Mutations; Single-nucleotide polymorphisms; Urinary tract infection; Whole genome sequencing

Mesh:

Year:  2016        PMID: 27825516      PMCID: PMC5209455          DOI: 10.1016/j.ijmm.2016.10.005

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  57 in total

1.  Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011.

Authors:  Yonatan H Grad; Marc Lipsitch; Michael Feldgarden; Harindra M Arachchi; Gustavo C Cerqueira; Michael Fitzgerald; Paul Godfrey; Brian J Haas; Cheryl I Murphy; Carsten Russ; Sean Sykes; Bruce J Walker; Jennifer R Wortman; Sarah Young; Qiandong Zeng; Amr Abouelleil; James Bochicchio; Sara Chauvin; Timothy Desmet; Sharvari Gujja; Caryn McCowan; Anna Montmayeur; Scott Steelman; Jakob Frimodt-Møller; Andreas M Petersen; Carsten Struve; Karen A Krogfelt; Edouard Bingen; François-Xavier Weill; Eric S Lander; Chad Nusbaum; Bruce W Birren; Deborah T Hung; William P Hanage
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

2.  Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic.

Authors:  Karen L Nielsen; Thomas M Pedersen; Klas I Udekwu; Andreas Petersen; Robert L Skov; Lars H Hansen; Diarmaid Hughes; Niels Frimodt-Møller
Journal:  J Antimicrob Chemother       Date:  2012-02-29       Impact factor: 5.790

3.  Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation.

Authors:  Karen Ejrnæs; Marc Stegger; Andreas Reisner; Sven Ferry; Tor Monsen; Stig E Holm; Bettina Lundgren; Niels Frimodt-Møller
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

4.  Escherichia coli S fimbriae do not contribute to intestinal colonization or translocation in the gnotobiotic rat.

Authors:  V M Herías; A K Robertson; T Midtvedt; A E Wold
Journal:  Microb Pathog       Date:  2001-08       Impact factor: 3.738

5.  Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.

Authors:  Swaine L Chen; Chia S Hung; Jerome S Pinkner; Jennifer N Walker; Corinne K Cusumano; Zhaoli Li; Julie Bouckaert; Jeffrey I Gordon; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

6.  Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection.

Authors:  Karen L Nielsen; Pia Dynesen; Preben Larsen; Niels Frimodt-Møller
Journal:  J Med Microbiol       Date:  2014-01-25       Impact factor: 2.472

7.  Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method.

Authors:  David M Gordon; Olivier Clermont; Heather Tolley; Erick Denamur
Journal:  Environ Microbiol       Date:  2008-06-02       Impact factor: 5.491

8.  Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract.

Authors:  Glen C Ulett; Jaione Valle; Christophe Beloin; Orla Sherlock; Jean-Marc Ghigo; Mark A Schembri
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441

9.  Genomic analysis of extra-intestinal pathogenic Escherichia coli urosepsis.

Authors:  A McNally; F Alhashash; M Collins; A Alqasim; K Paszckiewicz; V Weston; M Diggle
Journal:  Clin Microbiol Infect       Date:  2013-04-10       Impact factor: 8.067

10.  PHAST: a fast phage search tool.

Authors:  You Zhou; Yongjie Liang; Karlene H Lynch; Jonathan J Dennis; David S Wishart
Journal:  Nucleic Acids Res       Date:  2011-06-14       Impact factor: 16.971

View more
  7 in total

1.  Whole-genome comparison of urinary pathogenic Escherichia coli and faecal isolates of UTI patients and healthy controls.

Authors:  Karen Leth Nielsen; Marc Stegger; Kristoffer Kiil; Paul A Godfrey; Michael Feldgarden; Berit Lilje; Paal S Andersen; Niels Frimodt-Møller
Journal:  Int J Med Microbiol       Date:  2017-09-14       Impact factor: 3.473

2.  Escherichia coli Clonobiome: Assessing the Strain Diversity in Feces and Urine by Deep Amplicon Sequencing.

Authors:  Sofiya G Shevchenko; Matthew Radey; Veronika Tchesnokova; Dagmara Kisiela; Evgeni V Sokurenko
Journal:  Appl Environ Microbiol       Date:  2019-11-14       Impact factor: 4.792

3.  Mutational change of CTX-M-15 to CTX-M-127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient.

Authors:  Karen Leth Nielsen; Katrine Hartung Hansen; Jesper Boye Nielsen; Jenny Dahl Knudsen; Kristian Schønning; Niels Frimodt-Møller; Frederik Boëtius Hertz; Filip Jansåker
Journal:  Microbiologyopen       Date:  2019-10-01       Impact factor: 3.139

4.  Genomic diversity of Escherichia coli from healthy children in rural Gambia.

Authors:  Ebenezer Foster-Nyarko; Nabil-Fareed Alikhan; Usman N Ikumapayi; Golam Sarwar; Catherine Okoi; Peggy-Estelle Maguiagueu Tientcheu; Marianne Defernez; Justin O'Grady; Martin Antonio; Mark J Pallen
Journal:  PeerJ       Date:  2021-01-06       Impact factor: 2.984

5.  Genomic analysis of trimethoprim-resistant extraintestinal pathogenic Escherichia coli and recurrent urinary tract infections.

Authors:  Dmitriy Li; Cameron J Reid; Timothy Kudinha; Veronica M Jarocki; Steven P Djordjevic
Journal:  Microb Genom       Date:  2020-11-18

6.  Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli.

Authors:  Nicole L Podnecky; Elizabeth G A Fredheim; Julia Kloos; Vidar Sørum; Raul Primicerio; Adam P Roberts; Daniel E Rozen; Ørjan Samuelsen; Pål J Johnsen
Journal:  Nat Commun       Date:  2018-09-10       Impact factor: 14.919

7.  Escherichia coli Causing Recurrent Urinary Tract Infections: Comparison to Non-Recurrent Isolates and Genomic Adaptation in Recurrent Infections.

Authors:  Karen Leth Nielsen; Marc Stegger; Kristoffer Kiil; Berit Lilje; Karen Ejrnæs; Rikke Fleron Leihof; Line Skjøt-Rasmussen; Paul Godfrey; Tor Monsen; Sven Ferry; Anette M Hammerum; Niels Frimodt-Møller
Journal:  Microorganisms       Date:  2021-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.